$AGL

agilon health, inc.

CIK:0001831097|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenues:
Total revenues	$ 1,494,743	$ 1,394,982	$ 2,915,203	$ 2,927,764
Expenses:
General and administrative	88,505	56,281	142,736	122,237
Depreciation and amortization	6,864	7,319	13,651	14,195
Total expenses	1,482,973	1,511,009	2,899,436	3,065,901
Income (loss) from operations	11,770	(116,027)	15,767	(138,137)
Other income (expense):
Income (loss) from equity method investments	(7,596)	5,412	4,137	18,084
Other income (expense), net	15,015	7,879	31,040	17,140
Interest expense	(1,608)	(1,572)	(3,419)	(3,087)
Income (loss) before income taxes	17,581	(104,308)	47,525	(106,000)
Income tax benefit (expense)	375	(62)	347	(258)
Income (loss) from continuing operations	17,956	(104,370)	47,872	(106,258)
Discontinued operations:
Adjustments on sale of assets, net	0	0	19,000	14,000
Net income (loss)	$ 17,956	$ (104,370)	$ 66,872	$ (92,258)
Basic earnings per common share:
Continuing operations (in dollars per share)	$ 1.07	$ (6.31)	$ 2.88	$ (6.43)
Discontinued operations (in dollars per share)	0	0	1.14	0.85
Net income (loss) (in dollars per share)	1.07	(6.31)	4.02	(5.58)
Diluted earnings per common share:
Continuing operations (in dollars per share)	1.04	(6.31)	2.84	(6.43)
Discontinued operations (in dollars per share)	0	0	1.12	0.85
Net income (loss) (in dollars per share)	$ 1.04	$ (6.31)	$ 3.96	$ (5.58)
Weighted average shares outstanding
Basic (in shares)	16,705	16,553	16,653	16,535
Diluted (in shares)	17,213	16,553	16,884	16,535
Medical services revenue
Revenues:
Total revenues	$ 1,492,921	$ 1,392,039	$ 2,911,470	$ 2,921,918
Expenses:
Expenses	1,296,235	1,445,245	2,565,863	2,847,112
Other operating revenue
Revenues:
Total revenues	1,822	2,943	3,733	5,846
Expenses:
Expenses	$ 91,369	$ 2,164	$ 177,186	$ 82,357

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income (loss)	$ 66,872	$ (92,258)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	13,651	14,195
Stock-based compensation expense	30,087	32,101
Loss (income) from equity method investments	(4,137)	(18,084)
Adjustments on sale of assets, net	(19,000)	(14,000)
Other, net	1,377	(3,107)
Changes in operating assets and liabilities	(122,419)	14,081
Net cash provided by (used in) operating activities	(33,569)	(67,072)
Cash flows from investing activities:
Purchases of property, equipment, and capitalized software	(6,548)	(7,099)
Purchase of intangible assets	(885)	(9,717)
Investment in loans receivable and other	0	(1,000)
Investments in marketable securities	0	(60,154)
Proceeds from maturities of marketable securities and other	46,616	125,339
Net cash provided by (used in) investing activities	39,183	47,369
Cash flows from financing activities:
Proceeds from (payments for) equity issuances, net	4,596	(2,741)
Debt issuance costs	(1,612)	0
Repayments of long-term debt	(3,500)	0
Net cash provided by (used in) financing activities	(516)	(2,741)
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	5,098	(22,444)
Cash, cash equivalents and restricted cash and equivalents, beginning of period	173,713	193,860
Cash, cash equivalents and restricted cash and equivalents, end of period	$ 178,811	$ 171,416

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 107,184	$ 173,713
Restricted cash and equivalents	71,627	0
Marketable securities	78,443	111,429
Receivables, net	1,059,786	673,793
Prepaid expenses and other current assets, net	101,494	137,762
Total current assets	1,418,534	1,096,697
Property, equipment, and capitalized software, net	24,513	25,417
Intangible assets, net	60,132	65,725
Other assets	88,157	83,451
Total assets	1,591,336	1,271,290
Current liabilities:
Medical claims and related payables	1,022,506	929,770
Accounts payable and accrued expenses	274,928	127,477
Current debt	14,915	19,238
Total current liabilities	1,312,349	1,076,485
Long-term debt	15,377	15,750
Other liabilities	36,083	52,321
Total liabilities	1,363,809	1,144,556
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $0.01 par value: 2,000,000 shares authorized; 16,785 and 16,589 shares issued and outstanding, respectively	168	166
Additional paid-in capital	2,138,657	2,103,976
Accumulated deficit	(1,911,452)	(1,978,324)
Accumulated other comprehensive income (loss)	154	916
Total stockholders’ equity (deficit)	227,527	126,734
Total liabilities and stockholders’ equity (deficit)	$ 1,591,336	$ 1,271,290